cas 150993-62-7|| where to buy 2-Pyrrolidinecarbonyl chloride, 1-[7-[(dimethylamino)sulfonyl]-2,1,3-benzoxadiazol-4-yl]-, (2R)- (9CI)

Produktname:2-Pyrrolidinecarbonyl chloride, 1-[7-[(dimethylamino)sulfonyl]-2,1,3-benzoxadiazol-4-yl]-, (2R)- (9CI)

IUPAC Name:(2R)-1-[7-(dimethylsulfamoyl)-2,1,3-benzoxadiazol-4-yl]pyrrolidine-2-carbonyl chloride

: CAS：150993-62-7; Molekulare Formel：C13H15ClN4O4S; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM455465-50mg	3-4 Weeks	ȃȃŹ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 150993-62-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:150993-62-7; Molekulare Formel:C13H15ClN4O4S; Schmelzpunkt:-; SMILES-Code:CN(C)S(=O)(=O)C1=CC=C(N2CCC[C@@H]2C(Cl)=O)C2=NON=C12; Dichte:

: Katalognummer:CM455465; Molekulargewicht:358.8; Siedepunkt:; Mdl-Nr.:MFCD00221513; Lagerung:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Benzofurazans; Benzofurazans are important pharmaceutical intermediates. Benzofurazans are known bioisosteres of the nitro group. Both oxadiazoles and nitro groups have strong electron-withdrawing properties, but when optimizing drug-like properties such as activity, selectivity, and stability, the absence of standard charges in the oxadiazole structure may be more beneficial to drug products. What's more, nitro groups have been identified as toxic groups, and it is routine to remove or replace them in the early stages of drug development.